Abstract
Final evaluation of the Infusaid Pump system (Infusaid Corporation, Sharon, MA) for administration of regional chemotherapy must await completion of trials prospectively comparing survival of matched patients treated in this manner and patients treated by traditional systemic chemotherapy. A review of the current medical literature confirms our personal experience that response rates within the liver are high. Survival reports appear encouraging but this may represent an artifact in patient selection. An algorithm is presented to offer surgeons a reasonable and conservative means for selection of those colorectal cancer patients with metastatic involvement of the liver who are most likely to benefit from this system of drug delivery.
Similar content being viewed by others
References
Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. Cancer 1969;23:198–202.
Bengtsson G, Carlsson G, Hafstrom L, Jonsson P. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586–9.
Jaffe BM, Donegan WL, Watson F, Spratt JS Jr. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968;127:1–11.
Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285–8.
Bedikian AY. Regional and systemic chemotherapy for advanced colorectal cancer: a review. Dis Colon Rectum 1983;26:327–32.
Hahn RG, Moertel CG, Schutt AJ, Bruckner HW. A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer 1975;35:1031–5.
Lokich J, Bothe A, Fine N, Perri J. Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 1981;48:2565–8.
Moertel CG. Clinical management of advanced gastrointestinal cancer. Cancer 1975;36:675–82.
Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978;135:389–94.
Adson MA, van Heerden JA. Major hepatic resections for metastatic colorectal cancer. Ann Surg 1980;191:576–83.
Fortner JG, Dong KK, Maclean BJ, et al. Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg 1978;188:363–71.
Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 1976;111:330–4.
Flanagan L Jr, Foster JH. Hepatic resection for metastatic cancer. Am J Surg 1967;113:551–7.
Fortner JG, Silva JS, Golbey RB, Cox EB, Maclean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer: I. Treatment by hepatic resection. Ann Surg 1984;199:306–16.
Blackshear PJ, Frank D, Dorman P, Blackshear PL Jr, Varco RL, Buchwald H. The design and initial testing of an implantable infusion pump. Surg Gynecol Obstet 1972;134:51–6.
Balch CM, Urist MM, Soong S-J, McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983;198:567–73.
Balch CM, Urist MM, McGregor ML. Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg 1983;145:290.
Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 1982;50:850–62.
Cohen AM, Kaufman SD, Wood WC, Greenfield AJ. Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 1983;145:529–33.
Ensminger W, Niederhuber J, Shaker D, Thrall J, Wheeler R. Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 1981;65:393–400.
Ensminger W, Niederhuber GJ, Thrall J, Cozzi E, Doan K. Effective control of liver metastases from colon cancer with an implanted system for hepatic arterial chemotherapy. Proc Ann Meet Am Soc Clin Oncol 1982;1:C-363.
Fortner JG, Silva JS, Cox EB, Golbey RB, Gallowitz H, Maclean BJ. Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer: II. Treatment by intrahepatic chemotherapy. Ann Surg 1984;199:317–24.
Levin B, Karl R, DuBrow R, Cooper M, Hagle M, Cooper R. Regional hepatic chemotherapy for metastatic cancer with an implanted drug infusion system. Clin Res 1982;30:783A.
Weiss GR, Garnick MB, Osteen RT, et al. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol 1983;1:337–44.
Kempf P, Olbermann M, Fischer J. Improved quality of life with an implantable pump for liver perfusion. Recent Results Cancer Res 1983;86:87–9.
Cohen AM, Wood WC, Greenfield A, Waltman A, Dedrick C, Blackshear PJ. Transbrachial hepatic arterial chemotherapy using an implanted infusion pump. Dis Colon Rectum 1980;23:223–7.
Oberfield RA. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Recent Results Cancer Res 1983;86:49–62.
Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 1978;38:3784–92.
Author information
Authors and Affiliations
Additional information
Read at the Joint Meeting of the American Society of Colon and Rectal Surgeons with the Section of Colo-Proctology, Royal Society of Medicine, and the Section of Colonic and Rectal Surgery, Royal Australasian College of Surgeons, New Orleans, Louisiana, May 6 to 11, 1984.
About this article
Cite this article
Oliver, G.C., Shorb, P.E. The totally implantable Infusion Pump in treatment of metastatic colorectal cancer. Dis Colon Rectum 28, 18–23 (1985). https://doi.org/10.1007/BF02553900
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02553900